Frequently Asked Questions
The market is segmented based on The size in 2023 is USD 53.33 billion. The market share is projected to grow at a CAGR of 14.00% and reach USD 133.45 billion by 2031.
.
The Global Cancer Monoclonal Antibodies Market size was valued at USD 53.33 USD Billion in 2023.
The Global Cancer Monoclonal Antibodies Market is projected to grow at a CAGR of 14% during the forecast period of 2024 to 2031.
The major players operating in the market include F. Hoffmann La Roche , Mylan N.V., Sanofi, Pfizer , GSK plc, Novartis AG, Bayer AG, Lilly, Merck & Co. , Sun Pharmaceutical Industries , Aurobindo Pharma, Lupin, Fresenius Kabi AG, Akorn orporated, Teva Pharmaceutical Industries .
